Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of a UTI Vaccine (GSKVX000000046019) for Adults Aged 18-64 and Women Aged 18-64 with Urinary Tract Infections

    Not recruiting

    2 1
    Belgium Spain
  • Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia Denmark Finland Germany Poland Romania
  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18+ with Lung or Kidney Transplants at Risk of RSV Infections, Compared to Healthy Adults 50+

    Not recruiting

    2 1 1 1
    Germany Italy Spain
  • Study on the Effectiveness of the 9-Valent HPV Vaccine in Children and Adolescents with Weakened Immune Systems

    Not recruiting

    3 1 1 1
    Spain
  • Study on the Safety and Immune Response of a New Influenza Vaccine with GSKVX000000034794 in Healthy Younger and Older Adults

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on the Effectiveness and Safety of OVX836 Vaccine for Preventing Influenza in Healthy Adults Aged 18-59

    Not recruiting

    2 1 1
    Investigated Diseases:
    Belgium Finland France Germany
  • Study on the Safety and Effects of Intranasal EV25 in Healthy Adults with and without Influenza Virus Exposure

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium
  • Study on Immune Responses to Influenza Vaccines in Health Care Workers Using Polysorbate 80, Sodium Citrate, and Citric Acid Anhydrous

    Not recruiting

    3 1 1 1
    Finland
  • Study on the Safety and Immune Response of mRNA-1345 Vaccine for Respiratory Syncytial Virus in Pregnant Women and Their Infants

    Not recruiting

    2 1 1
    Denmark
  • Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy The Netherlands Poland +1
  • Study on Mycobacterium Bovis Bacillus Calmette-Guérin for High-risk Non-muscle Invasive Bladder Cancer Patients

    Not recruiting

    2 1 1
    Spain
  • Study of BT-001 and Pembrolizumab for Patients with Advanced Solid Tumors, Including Sarcoma, Merkel Cell Carcinoma, Melanoma, Breast, and Lung Cancer

    Not recruiting

    2 1 1 1
    Belgium France